Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma

Thoracic Surgery Clinics

Volumn 14, Issue 4 SPEC. ISS., 2004, Pages 505-516

  Paul, Subroto ^a   Neragi Miandoab, Siyamek ^a   Jaklitsch, Michael T ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BLEOMYCIN; CISPLATIN; CYANOCOBALAMIN; FENTANYL; FOLIC ACID; GEMCITABINE; NARCOTIC AGENT; OXALIPLATIN; PEMETREXED; PLATINUM; RALTITREXED; TETRACYCLINE; THYMIDYLATE SYNTHASE INHIBITOR;

ANALGESIA; BLEEDING; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PAIN; CANCER RADIOTHERAPY; CLINICAL TRIAL; EMPYEMA; EPIDURAL CATHETER; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG RESECTION; LUNG VENTILATION PERFUSION RATIO; PALLIATIVE THERAPY; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURECTOMY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SIDE EFFECT; SUBCUTANEOUS EMPHYSEMA; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT PLANNING; VOCAL CORD PARALYSIS;

EID: 4744363264     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2004.06.008     Document Type: Review

References (55)

1. K. Antman, H. Pass, and A. Recht Benign and malignant mesothelioma V. DeVita S. Hellman S. Rosenberg Cancer: principles and practice of oncology 1989 JB Lippincott Co. Philadelphia 1399 1414
2. N. Martini, P.M. McCormack, M.S. Bains, L.R. Kaiser, M.E. Burt, and B.S. Hilaris Pleural mesothelioma Ann Thorac Surg 43 1987 113 120
3. D. Sugarbaker, R. Flores, M. Jaklitsch, W. Richards, G. Strauss, and J. Corson Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 63
4. D. Sugarbaker, M. Jaklitsch, A. Soutter, J. Aisner, and K. Antman Multimodality therapy of malignant mesothelioma J.A. Roth J.C. Ruckdeschel T.H. Weisenburger Thoracic oncology 1994 WB Saunders Philadelphia 538 555
5. J. Aisner Current approach to malignant mesothelioma of the pleura Chest 106 6 Suppl 1995 332S 334S
6. D. Sugarbaker, M. Jaklitsch, and M. Liptay Mesothelioma and radical multimodality therapy: who benefits? Chest 107 6 Suppl 1995 345S 350S
7. A.E. Fraire, S. Cooper, S.D. Greenberg, P. Buffler, and C. Langston Mesothelioma of childhood Cancer 62 1988 838 847
8. G. Maggi, C. Casadio, R. Cianci, O. Rena, and E. Ruffini Trimodality management of malignant pleural mesothelioma Eur J Cardiothorac Surg 19 2001 346 350
9. J. Garcia, W. Richards, and D. Sugarbaker Surgical treatment of malignant mesothelioma L. Kaiser I. Kron T. Spray Mastery of cardiothoracic surgery 1998 Lippincott-Raven Philadelphia 230 236
10. M.T. Jaklitsch, S.C. Grondin, and D.J. Sugarbaker Treatment of malignant mesothelioma World J Surg 25 2001 210 217
11. C. Boutin, M. Schlesser, C. Frenay, and P.H. Astoul Malignant pleural mesothelioma Eur Respir J 12 1998 972 981
12. R. Connelly, R. Spirtas, and M. Myers Demographic patterns for mesothelioma in the United States J Natl Cancer Inst 78 1987 1053 1060
13. T. Aziz, A. Jilaihawi, and D. Prakash The management of malignant pleural mesothelioma; single centre experience in 10 years Eur J Cardiothorac Surg 22 2002 298 305
14. G.L. Ceresoli, L.D. Locati, A.J. Ferreri, C. Cozzarini, P. Passoni, and G. Melloni Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma Lung Cancer 34 2001 279 287
15. W.J. Miller, W.B. Gefter, and W.T. Miller Asbestos-related chest diseases: plain radiographic findings Semin Roentgenol 27 1992 102 120
16. U.M. Yilmaz, G. Utkaner, E. Yalniz, and Z. Kumcuoglu Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma Respirology 3 1998 33 38
17. G. Layer, H. Schmitteckert, A. Steudel, S. Tuengerthal, J. Schirren, and G. van Kaick MRT, CT and sonography in the preoperative assessment of the primary tumor spread in malignant pleural mesothelioma Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 170 1999 365 370
18. V.W. Rusch, J.D. Godwin, and W.P. Shuman The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma J Thorac Cardiovasc Surg 96 1988 171 177
19. E.F. Patz Jr, K. Shaffer, D.R. Piwnica-Worms, M. Jochelson, M. Sarin, and D.J. Sugarbaker Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability AJR Am J Roentgenol 159 1992 961 966
20. D.J. Sugarbaker, S.J. Mentzer, and G. Strauss Extrapleural pneumonectomy in the treatment of malignant, pleural mesothelioma Ann Thorac Surg 54 1992 941 946
21. D. Sterman, L. Kaiser, and S. Albelda Advances in the treatment of malignant pleural mesothelioma Chest 116 1999 504 520
22. D.B. Schneider, C. Clary-Macy, S. Challa, K.C. Sasse, S.H. Merrick, and R. Hawkins Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma J Thorac Cardiovasc Surg 120 2000 128 133
23. A. Teirstein Diagnosing malignant pleural mesothelioma Chest 114 1998 713 722
24. M.W. Grossebner, A.A. Arifi, M. Goddard, and A.J. Ritchie Mesothelioma: VATS biopsy and lung mobilization improves diagnosis and palliation Eur J Cardiothorac Surg 16 1999 619 623
25. G.J. Gordon, R.V. Jensen, L.L. Hsiao, S.R. Gullans, J.E. Blumenstock, and S. Ramaswamy Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma Cancer Res 62 2002 4963 4967
26. C. Boutin, R. Loddenkemper, and P. Astoul Diagnostic and therapeutic thoracoscopy: techniques and indications in pulmonary medicine Tuber Lung Dis 74 1993 225 239
27. C. Boutin, F. Rey, and J.R. Viallat Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy Chest 108 1995 754 758
28. E. Cibas, J. Corson, and G. Pinkus The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen Hum Pathol 18 1987 67 74
29. A. Montag, G. Pinkus, and J. Corson Keratin protein immunoreactivity of sarcomatoid and mixed types of diffuse malignant mesothelioma: an immunoperoxidase study of 30 cases Hum Pathol 19 1988 336 342
30. C. O'Hara, J. Corson, G. Pinkus, and R. Stahel ME1: a monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extra pulmonary malignancies Am J Pathol 136 1990 421 428
31. A.S. Abutaily, B.J. Addis, and W.R. Roche Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies J Clin Pathol 55 2002 662 668
32. G. Gordon, R. Jensen, L.-L. Hsiao, S. Gullans, J. Blumenstock, and W. Richards Using gene expression ratios to predict outcome among patients with mesothelioma J Natl Cancer Inst 95 2003 598 605
33. G. Gordon, W. Richards, D. Sugarbaker, M. Jaklitsch, and R. Bueno A prognostic test for adenocarcinoma of the lung from gene expression profiling data Cancer Epidemiology, Biomarkers, and Prevention 12 2003 905 910
34. E.G. Butchart, T. Ashcroft, W.C. Barnsley, and M.P. Holden Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients Thorax 31 1976 15 24
35. V.W. Rusch Group TIMI A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group Chest 108 1995 1122 1128
36. D.J. Sugarbaker, S.J. Mentzer, M. DeCauld, T.J. Lynch Jr, and G.M. Strauss Extrapleural pneumonectomy or pleurectomy in the setting of a multimodality approach to malignant mesothelioma Chest 104 1993 3775 3815
37. D.J. Sugarbaker, J.P. Garcia, W.G. Richards, D.H. Harpole Jr, E. Healy-Baldini, and M.M. DeCamp Jr Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients Ann Surg 224 1996 288 294
38. Sugarbaker D., Jaklitsch M., Bueno R., Richards W., Lukanich J., Mentzer S., et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg, in press
39. D.J. Sugarbaker, and J.P. Garcia Multimodality therapy for malignant pleural mesothelioma Chest 112 1997 272S 275S
40. H. Pass, B. Temeck, K. Kranda, S. Steinberg, and I. Feuerstein Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma J Thorac Cardiovasc Surg 115 1998 310 317 discussion 317â€"8
41. H.I. Pass, and H.W. Pogrebniak Malignant pleural mesothelioma Curr Probl Surg 30 1993 921 1012
42. A.E. Martin-Ucar, J.G. Edwards, A. Rengajaran, S. Muller, and D.A. Waller Palliative surgical debulking in malignant mesothelioma: predictors of survival and symptom control Eur J Cardiothorac Surg 20 2001 1117 1121
43. Brancatisano R.P., Joseph M.G., McCaughan B.C. Pleurectomy for mesothelioma. Med J Aust 1991:154;455-7, 460
44. S. Tomek, and C. Manegold Chemotherapy for malignant pleural mesothelioma Curr Opin Oncol 15 2003 148 156
45. N.J. Vogelzang Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma? J Clin Oncol 17 1999 2626 2627
46. A.G. Favaretto, S.M. Aversa, A. Paccagnella, P. Manzini Vde, V. Palmisano, and F. Oniga Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study Cancer 97 2003 2791 2797
47. C. Manegold Pemetrexed: current development and future directions in thoracic cancers Suppl Tumori 1 2002 S11 S12
48. N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel, and P. Ruffie Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2003 2636 2644
49. A. Ahamad, C. Stevens, W. Smythe, A. Vaporciyan, R. Komaki, and J. Kelly Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 55 2003 768 775
50. D.L. Ball, and D.G. Cruickshank The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy Am J Clin Oncol 13 1990 4 9
51. D. Bissett, F.R. Macbeth, and I. Cram The role of palliative radiotherapy in malignant mesothelioma Clin Oncol (R Coll Radiol) 3 1991 315 317
52. S. Yajnik, K.E. Rosenzweig, B. Mychalczak, L. Krug, R. Flores, and L. Hong Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 56 2003 1319 1326
53. S. Senan Indications and limitations of radiotherapy in malignant pleural mesothelioma Curr Opin Oncol 15 2003 144 147
54. A.M. Averbach, and P.H. Sugarbaker Peritoneal mesothelioma: treatment approach based on natural history Cancer Treat Res 81 1996 193 211
55. S. Davis, L. Tan, and D. Ball Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation Australas Radiol 38 1994 212 214